Development of hyperfimbriated strains of Vibrio cholerae O1

被引:1
作者
Ehara, M [1 ]
Iwami, M [1 ]
Ichinose, Y [1 ]
Hirayama, T [1 ]
机构
[1] Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan
关键词
cholera vaccine; type; 4; fimbriae; hyperfimbriated strain; overproduction vector;
D O I
10.1111/j.1348-0421.2000.tb02518.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The I:Vibrio cholerae O1 and O139 fimbrillin genes (fimA or mshA) were amplified by polymerase chain reaction and cloned into an Escherichia coli pCR(TM) vector, These clones were sequenced. The fimA sequences were found to be identical between TS cholerae O1 and O139, One of the plasmids was digested with EcoR I and inserted into the EcoR I site of pGEX-3X, The plasmid pVPP thus obtained was transferred into strains of wild-type V. cholerae O1 Bgd17 (classical in biotype) and its fimbriated strain by electroporation, The recombinant plasmid pVPP overexpressed mature fimbriae following induction of the tac promoter with isopropyl-beta-D-thiogalactopyranoside. The cloned gene product was purified to homogeneity by sucrose-linear gradient centrifugation (7.8 mg of fimbriae/L-culture), All the properties of the recombinant fimbriae (e.g., subunit structure, hydrophobicity, hemagglutinating activity sensitive to D-mannose and D-glucose and immunogenicity) were identical to those of the wild-type fimbriae. This overexpression system will be extremely useful for rapid, inexpensive preparation of large amounts of fimbriae for vaccine design and development.
引用
收藏
页码:439 / 446
页数:8
相关论文
共 28 条
[1]   Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers [J].
Chaicumpa, W ;
Chongsa-nguan, M ;
Kalambaheti, T ;
Wilairatana, PA ;
Srimanote, P ;
Makakunkijcharoen, Y ;
Looareesuwan, S ;
Sakolvaree, Y .
VACCINE, 1998, 16 (07) :678-684
[2]   B-SUBUNIT-WHOLE CELL AND WHOLE CELL-ONLY ORAL VACCINES AGAINST CHOLERA - STUDIES ON REACTOGENICITY AND IMMUNOGENICITY [J].
CLEMENS, JD ;
STANTON, BF ;
CHAKRABORTY, J ;
SACK, DA ;
KHAN, MR ;
HUDA, S ;
AHMED, F ;
HARRIS, JR ;
YUNUS, M ;
KHAN, MU ;
SVENNERHOLM, AM ;
JERTBORN, M ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (01) :79-85
[3]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS OF ONE-YEAR OF FOLLOW-UP [J].
CLEMENS, JD ;
HARRIS, JR ;
SACK, DA ;
CHAKRABORTY, J ;
AHMED, F ;
STANTON, BF ;
KHAN, MU ;
KAY, BA ;
HUDA, N ;
KHAN, MR ;
YUNUS, M ;
RAO, MR ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (01) :60-69
[4]  
COSTER TS, 1995, LANCET, V345, P949, DOI 10.1016/S0140-6736(95)90698-3
[5]  
Davis LG., 1986, Basic Methods in Molecular Biology
[6]   Induction of fimbriated Vibrio cholerae O139 [J].
Ehara, M ;
Iwami, M ;
Ichinose, Y ;
Hirayama, T ;
Albert, MJ ;
Sack, RB ;
Shimodori, S .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (01) :65-69
[7]  
EHARA M, 1994, FEMS MICROBIOL LETT, V123, P185, DOI 10.1016/0378-1097(94)90293-3
[8]  
Ehara M, 1997, FEMS MICROBIOL LETT, V154, P293, DOI 10.1016/S0378-1097(97)00345-5
[9]  
EHARA M, 1991, Tropical Medicine, V33, P109
[10]   IMMUNOGENICITY OF VIBRIO-CHOLERAE O1 FIMBRIAE IN ANIMAL AND HUMAN CHOLERA [J].
EHARA, M ;
ICHINOSE, Y ;
IWAMI, M ;
UTSUNOMIYA, A ;
SHIMODORI, S ;
KANGETHE, SK ;
NEVES, BC ;
SUPAWAT, K ;
NAKAMURA, S .
MICROBIOLOGY AND IMMUNOLOGY, 1993, 37 (09) :679-688